SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Mar-15 5:34 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 26-Feb-15 | Option Exercise | 50,000 | $1.66 | $83,000.00 | 1312% 3.81K to 53.81K | |
02-Mar-15 5:34 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 26-Feb-15 | Market Option Sale (Planned) | 50,000 | $5.68 | $284,200.00 | (93%) 53.81K to 3.81K | 94% |
05-Feb-15 5:33 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 30-May-14 | Grant | 4,218 | $5.25 | $22,144.50 | 111% 3.81K to 8.03K | |
11-Feb-14 7:32 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-Nov-13 | Grant | 3,810 | $5.34 | $20,345.40 | 100% 0 to 3.81K | |
29-Jul-13 7:50 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 26-Jul-13 | Option Exercise | 64,767 | $1.66 | $107,513.00 | 100% 0 to 64.77K | |
29-Jul-13 7:50 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 26-Jul-13 | Market Option Sale (Planned) | 64,767 | $7.55 | $489,083.00 | (100%) 64.77K to 0 | 96% |
12-Mar-13 8:26 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 11-Mar-13 | Option Exercise | 27,685 | $1.66 | $45,957.10 | 100% 0 to 27.68K | |
12-Mar-13 8:26 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 11-Mar-13 | Market Option Sale (Planned) | 27,685 | $6.67 | $184,659.00 | (100%) 27.68K to 0 | 95% |
18-Jan-13 6:02 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 15-Jan-13 | Option Exercise | 22,315 | $1.66 | $37,042.90 | 100% 0 to 22.32K | |
18-Jan-13 6:02 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 15-Jan-13 | Market Option Sale (Planned) | 22,315 | $6.67 | $148,842.00 | (100%) 22.32K to 0 | 95% |
29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-Jun-12 | Option Exercise | 103,309 | $1.66 | $171,493.00 | 100% 0 to 103.31K | |
29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-Jun-12 | Market Option Sale (Planned) | 103,309 | $5.66 | $584,729.00 | (100%) 103.31K to 0 | 94% |